Star Combo Pharma Ltd. · ASX:S66

Star Combo Pharma — Shareholder Meeting (November 2018)

12 slides from Star Combo Pharma's shareholder meeting presentation, Nov 28, 2018

1. Slide 1: Chairman's Address

   STAR COMBO PHARMA LTD ABN 38 6157 283 75 171 -177 Woodpark Rd Smithfield NSW 2164 P: +61 2 9756 6555 sales@starcombo.com.au 28 November 2018 2018 AGM Star Combo Pharma Limited Chairman’s Address _________________________________________________________________________ 2018 was a transformational yea

2. Slide 2: Chairman's Address (continued)

   STAR COMBO PHARMA LTD ABN 38 6157 283 75 171 -177 Woodpark Rd Smithfield NSW 2164 P: +61 2 9756 6555 sales@starcombo.com.au Looking forward, as you know we announced on 8 August 2018, the signing of a Heads of Agreement to acquire the Ausway Group of companies. We have very nearly completed our due

3. Slide 3: Presentation to 2018 Annual General Meeting

   Star Combo Pharma Ltd ASX: S66 Su Zhang – Chief Executive Officer Presentation to 2018 Annual General Meeting 28 November 2018

4. Slide 4: Disclaimer

   Star Combo Pharma Ltd _______________________________________________________________________________________________ Disclaimer This presentation contains information, ideas and analysis which are proprietary to Star Combo Pharma Ltd (ACN 615 728 375) (Star Combo or the Company). By agreeing to rec

5. Slide 5: 2018 Annual General Meeting

   Star Combo Pharma Ltd _______________________________________________________________________________________________ 2018 Annual General Meeting  Inaugural ASX financial result – record full year revenue of $10.9 million – growth of 11%  Gross Profit is $4.49 million, up 22%, with gross margin im

6. Slide 6: Growth Strategy

   Growth Strategy

7. Slide 7: Our Growth Strategy

   Star Combo Pharma Ltd _______________________________________________________________________________________________ Our Growth Strategy To obtain more distribution channels To Invest in marketing and promotional To invest in the research and and launch the Living Healthy Little activities to achie

8. Slide 8: Living Healthy Marketing Strategy

   Star Combo Pharma Ltd _______________________________________________________________________________________________ Living Healthy Marketing Strategy Improving social awareness and exposure  Social network: WeChat, Facebook & Instagram  KOL live broadcast  Outdoor Billboards China Social Ecomme

9. Slide 9: Living Healthy Sales Channel Strategy

   Star Combo Pharma Ltd _______________________________________________________________________________________________ Living Healthy Sales Channel Strategy Domestic Signed on Symbion (Market Cap 3.32B) as a distributor of Living Healthy  Terry White Chemmart Network– 450 pharmacies in Australia and

10. Slide 10: Developing Chinese Market – China Office

    Star Combo Pharma Ltd _______________________________________________________________________________________________ Developing Chinese Market – China Office • An official office for Star Combo Pharma Ltd based in China (Chongqing) is now incorporated as a wholly foreign-owned enterprise and was op

11. Slide 11: FY 2019 Outlook

    Star Combo Pharma Ltd _______________________________________________________________________________________________ FY 2019 Outlook • Group revenue for H1 FY19 (July – December 2018) is expected to grow by 12% - 15% compared to prior corresponding half year • Continued growth in our own brand segm

12. Slide 12: For further information

    For further information Su Zhang CEO E-mail: suzhang@starcombo.com.au 171 - 177 Woodpark Rd, Smithfield NSW 2164 Email: sales@starcombo.com.au Tel: +61 2 9756 6555 www.starcombo.com.au www.livinghealthy.com.au

Star Combo Pharma — Shareholder Meeting (November 2018) on 6ix